Pacific Biosciences Of California, Inc. shares fall 1.53% after-hours following Zentek Ltd.'s MD&A release.

Friday, Aug 15, 2025 7:23 pm ET1min read
PACB--
Pacific Biosciences Of California, Inc. declined 1.53% in after-hours trading. The recent news event, "Management's Discussion and Analysis For the three-month period ended June 30, 2025," dated August 14, 2025, may have contributed to the stock's decline. The report discusses the financial condition and results of operations of Zentek Ltd., which could have influenced investor sentiment negatively.

Pacific Biosciences Of California, Inc. shares fall 1.53% after-hours following Zentek Ltd.'s MD&A release.

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet